DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Jason Ward, a Partner within DRG’s Global Services Division, has extensive experience in the pricing and market access of pharmaceuticals at all stages of development and across many disease areas. He has delivered projects focusing on innovative pricing approaches at portfolio and individual brand level, including across indications.

Jason has been with DRG Consulting since 2015, and has successfully delivered global P&MA engagements across many therapy areas and stages of development.

Prior to DRG, Jason worked for a couple of years in consulting, preceded by 11 years at AstraZeneca, in a range of global P&MA roles, first as an individual contributor to many brand teams, and then as a team leader, responsible for the P&MA strategies for AZ’s R&D and pre-launch portfolio.

Jason has experience across many disease areas and all stages of drug development and commercialization. He has a special interest in drug development, spending five years at AZ focusing on how to build the views of payers into R&D plans and clinical trial programs.